UAB "CSO Pharma Baltic" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
311,406 |
31,423 |
10,169 |
9,775 |
986 |
0.20 |
0.34 |
30.84 |
3.14 |
67,789 |
23,356 |
418 |
92,419 |
2022 |
---|
312,708 |
33,990 |
19,230 |
-19,130 |
-2,079 |
0.13 |
0.70 |
34.19 |
-6.12 |
48,659 |
33,912 |
12,083 |
70,397 |
2023 |
---|
420,311 |
52,539 |
7,873 |
-7,868 |
-984 |
0.08 |
0.52 |
30.70 |
-1.87 |
40,791 |
21,120 |
8,175 |
55,752 |
Register and
explore Okredo data2023 |
---|
420,311 |
52,539 |
7,873 |
-7,868 |
-984 |
0.08 |
0.52 |
30.70 |
-1.87 |
40,791 |
21,120 |
8,175 |
55,752 |
Register and
explore Okredo data2023
Turnover (€)
420,311 €34 % *
Sales per employee (€)
52,539 €55 % *
Profit before tax (€)
7,873 €-59 % *
Net Profit (€)
-7,868 €59 % *
Profit per employee (€)
-984 €53 % *
Working capital requirement
0.08 -38.46 % *
Debt-to-equity ratio
0.52 -25.71 % *
Total profitability (%)
30.70 %-10.21 % *
Net profitability (%)
-1.87 %69.44 % *
Equity (€)
40,791 €-16 % *
Amounts Payable And Liabilities (€)
21,120 €-38 % *
Non-current Assets (€)
8,175 €-32 % *
CurrentAssets (€)
55,752 €-21 % *